Recent years have witnessed significant progresses in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://brendaoyrk186635.topbloghub.com/45464399/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements